Clover Health Investments, Corp

1. 01

   5.3 days to cover short interest

   25.9M shares were sold short at the 15 Oct 2026 settlement, 6.0% of the 435.4M shares outstanding; covering them would take 5.3 days of average volume. Short interest is reported twice a month, on a lag.

   Exchange short-interest filing · as of 15 Oct 2026

2. 02

   Ahead of SPY and its sector fund XLV over 1 year

   1 month: +2.0% (SPY −1.6%, XLV +13.5%). 3 months: +13.3% (SPY −0.4%, XLV +15.5%). 1 year: +33.2% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.

   Daily closes, split-adjusted: CLOV, SPY and XLV · as of 4 Nov 2026

3. 03

   Above its 50- and 200-day averages

   The 4 Nov 2026 close of $4.69 was 3.7% above its 50-day average ($4.52) and 31.4% above its 200-day average ($3.57). It has closed above the 200-day for 133 sessions, since 28 Apr 2026. The 50-day average crossed above the 200-day on 1 Jun 2026, 109 sessions ago.

   Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026

4. 04

   78% of the way up its 52-week range

   Closed at $4.69 on 4 Nov 2026: 16.1% below the 52-week high of $5.59 (29 Jun 2026) and 196.8% above the low of $1.58 (1 Apr 2026).

   Daily price bars, split-adjusted · as of 4 Nov 2026

5. 05

   Volume 1.8× its 30-session average on 4 Nov 2026

   4 Nov 2026 volume of 7.3M shares was 1.8× the average of the 30 sessions before it (4.0M), as the price rose 9.3%. SPY traded 1.5× its own average that session.

   Daily volume against a 30-session baseline · as of 4 Nov 2026

At the 4 Nov 2026 close